Clinical Development Hub
Local Demo
Home/deliverables/DEL 6209
Back to List

Deliverable Detail

Deliverable detail with SLA, acceptance criteria, and evidence. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.

Deliverable Detail

SLA Target
60
QC Findings
23
Acceptance Status
300

Acceptance and Evidence

To Do

Deliverable ID
DEL-6209
Current status
Submitted, pending sponsor review

In Review

SLA target
Turnaround 5 business days
Linked vendor
VENDOR-006

Done

Acceptance criteria
QC pass, metadata complete, approved template
Evidence
DOC-0008122

Add Acceptance and Evidence Entry

Access & Governance Controls
RBAC+ABACStudy Firewall Active

Operational Controls

Study firewalling chips highlight boundary, country constraints, and vendor partition rules.

Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.

Every state change writes immutable audit evidence with actor, timestamp, and object reference.

Next Actions

Filter to portfolio/program/study context.

Open linked tasks, risks, and document evidence.

Escalate blocked items through governed workflow.